#phase3 — Public Fediverse posts

https://www.europesays.com/dk/171659/ Novo’s CagriSema delivers superior weight loss versus #cagrisema #CopenhagenStockExchange:NOVOB #HbA1cReduction #NovoNordisk #NovoNordiskA/S #Phase3 #REDEFINE3 #REDEFINE9 #REIMAGINE5 #SuperiorWeightLoss #Tirzepatide #WeightReduction

DATE: September 14, 2026 at 09:51AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

New positive topline results from the second phase 3 study of DT120 (lysergide) ODT in adults with generalized anxiety disorder: a single dose delivered rapid, sustained anxiety relief. https://t.co/WCHftE5KAD

Here are any URLs found in the article text:

https://t.co/WCHftE5KAD

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #DT120 #Lysergide #GAD #Phase3 #AnxietyRelief

DATE: September 14, 2026 at 09:51AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

New positive topline results from the second phase 3 study of DT120 (lysergide) ODT in adults with generalized anxiety disorder: a single dose delivered rapid, sustained anxiety relief. https://t.co/WCHftE5KAD

Here are any URLs found in the article text:

https://t.co/WCHftE5KAD

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #DT120 #Lysergide #GAD #Phase3 #AnxietyRelief

DATE: September 14, 2026 at 09:51AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

New positive topline results from the second phase 3 study of DT120 (lysergide) ODT in adults with generalized anxiety disorder: a single dose delivered rapid, sustained anxiety relief. https://t.co/WCHftE5KAD

Here are any URLs found in the article text:

https://t.co/WCHftE5KAD

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #DT120 #Lysergide #GAD #Phase3 #AnxietyRelief

DATE: September 9, 2026 at 11:20AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

Newly published results from 2 phase 3 studies evaluating oveporexton in individuals with narcolepsy type 1 show that treatment with oveporexton led to statistically significant improvements over placebo on all measures. https://t.co/6FEuTfxRxz

Here are any URLs found in the article text:

https://t.co/6FEuTfxRxz

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Opevorexton #NarcolepsyType1 #Phase3 #ClinicalTrial #SleepMedicine

DATE: September 9, 2026 at 11:20AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

Newly published results from 2 phase 3 studies evaluating oveporexton in individuals with narcolepsy type 1 show that treatment with oveporexton led to statistically significant improvements over placebo on all measures. https://t.co/6FEuTfxRxz

Here are any URLs found in the article text:

https://t.co/6FEuTfxRxz

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Opevorexton #NarcolepsyType1 #Phase3 #ClinicalTrial #SleepMedicine

DATE: September 9, 2026 at 11:20AM
SOURCE: PSYCHIATRIC TIMES

Direct article link at end of text block below.

Newly published results from 2 phase 3 studies evaluating oveporexton in individuals with narcolepsy type 1 show that treatment with oveporexton led to statistically significant improvements over placebo on all measures. https://t.co/6FEuTfxRxz

Here are any URLs found in the article text:

https://t.co/6FEuTfxRxz

Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Opevorexton #NarcolepsyType1 #Phase3 #ClinicalTrial #SleepMedicine

https://www.europesays.com/at/381221/ PrevenTRON-Studie: p-tau217 im Blut sagt Alzheimer-Risiko voraus #AI #Alzheimer #ARTIFICIALINTELLIGENCE #AT #Austria #Biomarker #Bluttest #Dementz #Gesundheit #Health #KI #KlinischeStudie #KünstlicheIntelligenz #Österreich #PTau217 #Phase3 #Placebo #Roche #Surrey #Trongtinemab

Lambeth set to build Healthy Route extension with five new zebra crossings in West Dulwich

The council is proposing to install Phase 3 of the Healthy Route, extending it from the South Circular…
#London #Britain #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #Lambeth #BrockwellParktoGipsyHill #Cycleway #Cycling #extension #HealthyRoute #Phase3 #SouthCirculartoParkHallRoad #TransportStrategy
https://www.europesays.com/gbr/london/15330/

Fierce Pharma Asia—China’s IIT scrutiny; Daiichi Sankyo, AZ ph. 3 win; Leo, Tanabe’s dermatology deal

China’s investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of transparency.…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Asia #biosimilar #DaiichiSankyo #FiercePharmaAsia #FiercePharmaHomepage #genetherapy #MitsubishiTanabePharma #Pharma #phase3 #ShanghaiHenliusBiotechnology
https://www.europesays.com/britain/108180/

https://www.europesays.com/britain/108180/ Fierce Pharma Asia—China’s IIT scrutiny; Daiichi Sankyo, AZ ph. 3 win; Leo, Tanabe’s dermatology deal #Asia #AstraZeneca #biosimilar #DaiichiSankyo #FiercePharmaAsia #FiercePharmaHomepage #GeneTherapy #MitsubishiTanabePharma #Pharma #Phase3 #ShanghaiHenliusBiotechnology

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

https://twitter.com/NoubarAfeyan/status/2090050162441752787

Comments: https://news.ycombinator.com/item?id=49361395

#HackerNews #Moderna #mRNA #melanoma #therapy #Phase3 #positive #news #biotech #innovation #cancerresearch

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

https://twitter.com/NoubarAfeyan/status/2090050162441752787

Comments: https://news.ycombinator.com/item?id=49361395

#HackerNews #Moderna #mRNA #melanoma #therapy #Phase3 #positive #news #biotech #innovation #cancerresearch

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

https://twitter.com/NoubarAfeyan/status/2090050162441752787

Comments: https://news.ycombinator.com/item?id=49361395

#HackerNews #Moderna #mRNA #melanoma #therapy #Phase3 #positive #news #biotech #innovation #cancerresearch

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

https://twitter.com/NoubarAfeyan/status/2090050162441752787

Comments: https://news.ycombinator.com/item?id=49361395

#HackerNews #Moderna #mRNA #melanoma #therapy #Phase3 #positive #news #biotech #innovation #cancerresearch

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

https://twitter.com/NoubarAfeyan/status/2090050162441752787

Comments: https://news.ycombinator.com/item?id=49361395

#HackerNews #Moderna #mRNA #melanoma #therapy #Phase3 #positive #news #biotech #innovation #cancerresearch

https://www.europesays.com/iran/243741/ Lebanon faces tight deadline for landfill expansion #ChrisKilmer #Lebanon #Phase3 #Plainfield

A New Shingles Vaccine Posts 91.6% Efficacy in a 26,000-Person Trial

Our best stories, delivered daily. Follow us.

https://1ban.news/lz901-shingles-vaccine-phase3/

#1ban #lz901 #shingles #vaccine #phase3 #science

A New Shingles Vaccine Posts 91.6% Efficacy in a 26,000-Person Trial

Our best stories, delivered daily. Follow us.

https://1ban.news/lz901-shingles-vaccine-phase3/

#1ban #lz901 #shingles #vaccine #phase3 #science

A New Shingles Vaccine Posts 91.6% Efficacy in a 26,000-Person Trial

Our best stories, delivered daily. Follow us.

https://1ban.news/lz901-shingles-vaccine-phase3/

#1ban #lz901 #shingles #vaccine #phase3 #science

A New Shingles Vaccine Posts 91.6% Efficacy in a 26,000-Person Trial

Our best stories, delivered daily. Follow us.

https://1ban.news/lz901-shingles-vaccine-phase3/

#1ban #lz901 #shingles #vaccine #phase3 #science

A New Shingles Vaccine Posts 91.6% Efficacy in a 26,000-Person Trial

Our best stories, delivered daily. Follow us.

https://1ban.news/lz901-shingles-vaccine-phase3/

#1ban #lz901 #shingles #vaccine #phase3 #science

https://www.europesays.com/at/283903/ SGLT2- und GLP-1-Hemmer senken Alzheimer-Risiko: Neue Herz-Gehirn-Studien im Fokus #AI #Alzheimer #ARTIFICIALINTELLIGENCE #AT #Austria #Darmflora #Demenz #Entzündung #Epigenetik #Finerenon #Gesundheit #GLP1 #Health #herz #Hfpfef #Inhibitor #Kardiologie #Kardiometabolisch #KI #KlinischeStudie #KünstlicheIntelligenz #Melatonin #Österreich #Phase3 #Rezeptor #Roche #Schlaf #Screening #Sglt2

https://www.europesays.com/at/283543/ KI erkennt Alzheimer bis zu 7 Jahre früher und WHO setzt auf Prävention #AI #Alzheimer #ARTIFICIALINTELLIGENCE #AT #Austria #Bewegung #Biomarker #Bluttest #Dementia #Donanemab #Früherkennung #Gesundheit #Health #KI #KlinischeStudie #Kognition #KünstlicheIntelligenz #Lebensstil #Lecanemab #Medizin #Österreich #PTau #Phase3 #Roche #Sozial #Trontinemab #WHO

Viatris VR-205 Phase 3 IgAN Trial Hits Primary Endpoint

VR-205 Met Primary Endpoint and Key Secondary Endpoints and Was Well Tolerated VR-205 Efficacy and Safety Profile in…
#EuropeSays #Japan #JP #budesonide #IgAN #Japanese #nephrology #phase3 #Viatris #VR-205 #VTRS
https://www.europesays.com/japan/49492/

AbbVie wins EU approval for SKYRIZI in children

SKYRIZI® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #biopharma #EuropeanCommissionapproval #pediatricplaquepsoriasis #Phase3 #risankizumab #SKYRIZI
https://www.europesays.com/europe/77471/

https://www.europesays.com/at/232789/ CED-Forschung und Mercks Anti‑TL1A: Entzündungsgedächtnis bleibt, neue Therapie kommt #AT #Austria #Biomarker #CED #Cmv #ColitisUlcerosa #Darmkrebs #Einzelzellsequenzierung #Entzündungsgedächtnis #genetik #Gesundheit #Health #Il10 #Österreich #Phase3 #Tl1a #Tulisokibart #Zellkarte

NeuroSense gets South Korea patent for ALS drug PrimeC

Patent claims cover PrimeC’s proprietary formulation, manufacturing process and use in ALSExpands intellectual property protection in one of…
#EuropeSays #Korea #KR #ALS #biotech #NeuroSense #NRSN #patent #Phase3 #PrimeC #SouthKorea
https://www.europesays.com/korea/49665/

https://www.europesays.com/at/202757/ Bepirovirsen in Phase 3: 20% funktionelle Heilung bei chronischer Hepatitis B #Antisense #Antiviral #AT #Austria #Bepirovirsen #diagnose #Ersattung #FunktionelleHeilung #Gesundheit #Hbsag #Hbv #HbvDna #Health #Hepatitis #HepatitisB #Österreich #Phase3 #Sicherheit #Studie #Zulassung

https://www.europesays.com/dk/101492/ Novo Nordisk’s Pipeline Humming, but Shares Remain Stuck in Neutral #Humming #Neutral #Nordisk #Nordisk’s #novo #NovoNordisk #Phase3 #pipeline #remain #shares #stuck

https://www.europesays.com/at/181367/ AD109: Phase-3-Erfolg beschleunigt Zulassung für orale Therapie gegen obstruktive Schlafapnoe #Ahi #AT #Atemwege #Austria #CPAP #FDA #Gesundheit #Health #KlinischeStudie #Medikament #Neurobiologie #Obstruktiv #Österreich #Patientenversorgung #Phase3 #Schlafapnoe #Zulassung

You need to keep up your mental fitness—especially in Phase 2–3.

If the gym isn’t your thing, that’s fine.

Walk. Journal. Breathe.
Limit noise.

Your mind needs training too.
#PsychozoicEra #MentalFitness #Phase2 #Phase3

You need to keep up your mental fitness—especially in Phase 2–3.

If the gym isn’t your thing, that’s fine.

Walk. Journal. Breathe.
Limit noise.

Your mind needs training too.
#PsychozoicEra #MentalFitness #Phase2 #Phase3

You need to keep up your mental fitness—especially in Phase 2–3.

If the gym isn’t your thing, that’s fine.

Walk. Journal. Breathe.
Limit noise.

Your mind needs training too.
#PsychozoicEra #MentalFitness #Phase2 #Phase3

You need to keep up your mental fitness—especially in Phase 2–3.

If the gym isn’t your thing, that’s fine.

Walk. Journal. Breathe.
Limit noise.

Your mind needs training too.
#PsychozoicEra #MentalFitness #Phase2 #Phase3

Phase 3 is where it gets heavy.

You’ve outgrown your old life…
but your new one isn’t clear yet.

You feel stuck in between.

This is where most people quit.
#PsychozoicEra #Phase3 #TheReset #SelfGrowth

Phase 3 is where it gets heavy.

You’ve outgrown your old life…
but your new one isn’t clear yet.

You feel stuck in between.

This is where most people quit.
#PsychozoicEra #Phase3 #TheReset #SelfGrowth

Phase 3 is where it gets heavy.

You’ve outgrown your old life…
but your new one isn’t clear yet.

You feel stuck in between.

This is where most people quit.
#PsychozoicEra #Phase3 #TheReset #SelfGrowth

Phase 3 is where it gets heavy.

You’ve outgrown your old life…
but your new one isn’t clear yet.

You feel stuck in between.

This is where most people quit.
#PsychozoicEra #Phase3 #TheReset #SelfGrowth

Moderna wins EU authorization for flu-COVID vaccine

Moderna (NASDAQ:MRNA) received European Commission marketing authorization for mCOMBRIAX (mRNA-1083) on April 21,…
#Europe #EU #EuropeanCommission #adults50+ #combinationvaccine #covid-19 #EuropeanCommissionauthorization #influenza #Moderna #MRNA #Phase3
https://www.europesays.com/europe/19268/

https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ VarmX receives Phase 1 waiver from Japanese regulator PMDA #biotech #DrugDevelopment #Japan #JapanNews #Japanese #JapaneseNews #news #Phase3 #PMDA #VarmXB.V. VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 developmentRare waiver recognizes the global dat

https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ VarmX receives Phase 1 waiver from Japanese regulator PMDA #biotech #DrugDevelopment #Japan #JapanNews #Japanese #JapaneseNews #news #Phase3 #PMDA #VarmXB.V. VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 developmentRare waiver recognizes the global dat

VarmX receives Phase 1 waiver from Japanese regulator PMDA

VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 dev…
#Japan #JP #JapanNews #biotech #drugdevelopment #Japanese #Japanesenews #news #Phase3 #PMDA #VarmXB.V.
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/

VarmX receives Phase 1 waiver from Japanese regulator PMDA

VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 dev…
#Japan #JP #JapanNews #biotech #drugdevelopment #Japanese #Japanesenews #news #Phase3 #PMDA #VarmXB.V.
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/

Kochi Metro`s Phase 3 DPR study for the Aluva-Angamaly extension via Nedumbassery Airport is underway. The 17.5 km extension aims to enhance connectivity and improve airport access. https://english.mathrubhumi.com/news/kerala/kmrl-kicks-off-dpr-study-for-kochi-metros-phase-3-to-nedumbassery-airport-pvm9u9bq?utm_source=dlvr.it&utm_medium=mastodon #KochiMetro #Phase3 #MetroExtension #KMRL #SmartCity

Practice recap from Day 3 of Giants OTAs #shorts #nfl #giants #otas https://www.rawchili.com/4294280/ #2025OTAs #Football #Giants #Giants2025 #GiantsOffseason #GiantsOtas #GiantsOTAs2025 #GiantsPracticeReport #MetlifeStadium #NewYorkGiants #NewYorkGiants #NFC #NFCEast #NFL #NyGiants #OffseasonPractice #Phase3 #PracticeReport

Practice recap from Day 3 of Giants OTAs #shorts #nfl #giants #otas https://www.rawchili.com/4294280/ #2025OTAs #Football #Giants #Giants2025 #GiantsOffseason #GiantsOtas #GiantsOTAs2025 #GiantsPracticeReport #MetlifeStadium #NewYorkGiants #NewYorkGiants #NFC #NFCEast #NFL #NyGiants #OffseasonPractice #Phase3 #PracticeReport

MindMed, a pharmaceutical corporation that is not MAPS/Lykos, has several FDA-approved psychedelic studies in the works — #lsd analog for #anxiety and #depression and r-mdma form of #mdma for autism spectrum disorders #psychedelics #psychedelic #psychedelicresearch #psychedelicassistedtherapy #psychedelicmentalhealth #fda #phase2 #phase3 https://ir.mindmed.co/news-events/press-releases/detail/158/mindmed-reports-second-quarter-2024-financial-results-and-business-updates

MindMed, a pharmaceutical corporation that is not MAPS/Lykos, has several FDA-approved psychedelic studies in the works — #lsd analog for #anxiety and #depression and r-mdma form of #mdma for autism spectrum disorders #psychedelics #psychedelic #psychedelicresearch #psychedelicassistedtherapy #psychedelicmentalhealth #fda #phase2 #phase3 https://ir.mindmed.co/news-events/press-releases/detail/158/mindmed-reports-second-quarter-2024-financial-results-and-business-updates

MindMed, a pharmaceutical corporation that is not MAPS/Lykos, has several FDA-approved psychedelic studies in the works — #lsd analog for #anxiety and #depression and r-mdma form of #mdma for autism spectrum disorders #psychedelics #psychedelic #psychedelicresearch #psychedelicassistedtherapy #psychedelicmentalhealth #fda #phase2 #phase3 https://ir.mindmed.co/news-events/press-releases/detail/158/mindmed-reports-second-quarter-2024-financial-results-and-business-updates

MindMed, a pharmaceutical corporation that is not MAPS/Lykos, has several FDA-approved psychedelic studies in the works — #lsd analog for #anxiety and #depression and r-mdma form of #mdma for autism spectrum disorders #psychedelics #psychedelic #psychedelicresearch #psychedelicassistedtherapy #psychedelicmentalhealth #fda #phase2 #phase3 https://ir.mindmed.co/news-events/press-releases/detail/158/mindmed-reports-second-quarter-2024-financial-results-and-business-updates

Die neuen Ansichten im Website-Editor

WordPress 6.6 hat im Website-Editor neue Ansichten für Seiten und Templates, die als Basis für die weitere Entwicklung sehr vielversprechend aussehen. In diesem Beitrag stelle ich sie Ihnen kurz vor.

#Backend #Gutenberg #Phase3 #WebsiteEditor

https://einstieg-in-wp.de/wp66-website-editor-neue-ansichten/

Die neuen Ansichten im Website-Editor

WordPress 6.6 hat im Website-Editor neue Ansichten für Seiten und Templates, die als Basis für die weitere Entwicklung sehr vielversprechend aussehen. In diesem Beitrag stelle ich sie Ihnen kurz vor.

#Backend #Gutenberg #Phase3 #WebsiteEditor #WordPress66

https://einstieg-in-wp.de/wp66-website-editor-neue-ansichten/

Die neuen Ansichten im Website-Editor

WordPress 6.6 hat im Website-Editor neue Ansichten für Seiten und Templates, die als Basis für die weitere Entwicklung sehr vielversprechend aussehen. In diesem Beitrag stelle ich sie Ihnen kurz vor.

#Backend #Gutenberg #Phase3 #WebsiteEditor

https://einstieg-in-wp.de/wp66-website-editor-neue-ansichten/

Die neuen Ansichten im Website-Editor

https://einstieg-in-wp.de/wp66-website-editor-neue-ansichten/

https://www.evshift.com/260077/how-to-use-charging-on-the-go-dc-fast-charging-chevrolet-2/ How to Use Charging on the Go – DC Fast Charging | Chevrolet #2024 #2024_blazerEv #2024_blazer_ev #2024_equinoxEv #2024_equinox_ev #2024_silveradoEv #2024_silverado_ev #BlazerEv #charging #chevrolet #ElectricCars #ElectricVehicles #en_us #EquinoxEv #EV #fast #htw #Phase3 #Public #SilveradoEv

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://www.nature.com/articles/s41591-023-02565-4 #mdma-at #mdmaassistedtherapy #psychedelics #research #phase3 #ptsd

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://www.nature.com/articles/s41591-023-02565-4 #mdma-at #mdmaassistedtherapy #psychedelics #research #phase3 #ptsd

https://www.nature.com/articles/s41591-023-02565-4 #mdma #psychedelics #mdma-at #mdmaassistedtherapy #phase3

https://www.nature.com/articles/s41591-023-02565-4 #mdma #psychedelics #mdma-at #mdmaassistedtherapy #phase3